Mass balance study of [14C]-VAD044
Phase 1
Completed
- Conditions
- Vascular malformation
- Registration Number
- 2024-518843-39-00
- Lead Sponsor
- Vaderis Therapeutics AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ended
- Sex
- Not specified
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Pharma Bio-Research Group
🇳🇱Groningen, Netherlands
Pharma Bio-Research Group🇳🇱Groningen, NetherlandsJeroen van de WeteringSite contact+31504022502jeroenvande.wetering@iconplc.com